NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision Making
Recruiting · NCT05923684 · Interventional (participants receive a specific treatment) · Lead sponsor: Cedars-Sinai Medical Center
View the official record on ClinicalTrials.gov →Interventions studied
NLP-based Feedback
What this trial is about
In this pilot study, the investigators will show feasibility of the NLP-based feedback system in 20 consultations of men with newly diagnosed prostate cancer. The investigators will recruit from the practices of up to 10 physicians who typically see these patients. The investigators will report the top five sentences from each consultation across key content areas (cancer prognosis, life expectancy, erectile dysfunction, urinary incontinence, and irritative urinary symptoms) to both patients and physicians within 2 weeks of the consultation.
Who can take part
Age range
18 Years and older
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Men undergoing initial treatment consultation for clinically localized prostate cancer;
- Men with upgraded prostate cancer on active surveillance considering conversion to definitive local therapy.
- Cedars-Sinai patient.
- Ability to read and write in English.
Exclusion criteria
- Under 18 years of age;
- Subjects with difficulty communicating or dementia;
- Non-English speakers, given that our NLP-based tools cannot be used with languages other than English;
- Men with locally advanced or metastatic prostate cancer;
- Men who have already been treated for clinically localized prostate cancer
Where it is running
1 location listed across 1 US state.
- Cedars-Sinai Medical Center - Los Angeles, California, United States